Zdrowie i gospodarka · 13/05/2015

FDA Announces Public Meeting on Prescription Drug User Fee Act Reauthorization

The Food and Drug Administration is holding a public meeting to gather public input on the reauthorization of the Prescription Drug User Fee Act, which authorizes user fees for the review of human drugs, and is set to expire in September 2017.